Acorda Therapeutics
ACOR
#11268
Rank
C$1.17 M
Marketcap
C$0.95
Share price
0.00%
Change (1 day)
-95.54%
Change (1 year)

EPS for Acorda Therapeutics (ACOR)

EPS in 2024 (TTM): C-$67.87

According to Acorda Therapeutics 's latest financial reports the company's current EPS (TTM) is C-$71.98. In 2022 the company made an earnings per share (EPS) of C-$123.58 an increase over its 2021 EPS that were of C-$285.56.

EPS history for Acorda Therapeutics from 2012 to 2024

Annual EPS

Year EPS Change
2024 (TTM)C-$67.87
2022C-$123.58-56.72%
2021C-$285.56-16.13%
2020C-$340.50-65.51%
2019C-$987.15-898.61%
2018C$123.61-114.88%
2017C-$830.93536.84%
2016C-$130.48-392.31%
2015C$44.64-39.53%
2014C$73.824.88%
2013C$70.39-89.54%
2012C$672.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sarepta Therapeutics
SRPT
C-$3.76-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
C-$0.29-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
C-$7.48-89.61%๐Ÿ‡ฉ๐Ÿ‡ช Germany
BioMarin Pharmaceutical
BMRN
C-$0.13-99.82%๐Ÿ‡บ๐Ÿ‡ธ USA